Fractyl Health, INC Schedule 13G passive stakes

683 Capital Management, LLC, 683 Capital Partners, LP, and Ari Zweiman have reported beneficial ownership of 7,679,615 shares of Fractyl Health, Inc. common stock, representing 4.81% of the outstanding shares.

SilverArc Capital Management, LLC and Devesh Gandhi have reported beneficial ownership of 3,606,386 shares, representing 2.3% of Fractyl Health Inc.'s Class A Common Stock as of March 31, 2026.

Mithril LP and affiliated entities, including Ajay Royan and Peter Thiel, reported a decrease in their aggregate beneficial ownership of Fractyl Health, Inc. common stock to 4.7% due to the issuer's recent share sales.

CVF, LLC and HCC Manager LLC have filed an amended Schedule 13G, disclosing a combined beneficial ownership of 3.4% of Fractyl Health, Inc.'s common stock.

Alyeska Investment Group, L.P. and its affiliates have disclosed a 9.7% beneficial ownership stake in Fractyl Health's Class A Common Stock.

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, reported a 9.99% beneficial ownership stake in Fractyl Health, Inc. as of September 30, 2025.

Maverick Capital, along with its affiliates and Lee S. Ainslie III, reported a 3.1% beneficial ownership stake in Fractyl Health, Inc. as of September 30, 2025.

SilverArc Capital Management, LLC and Devesh Gandhi have reported a beneficial ownership of 8.02% of Fractyl Health, Inc.'s Class A Common Stock.

683 Capital Management, LLC and its affiliates have reported a beneficial ownership of 5.33% in Fractyl Health, Inc., totaling 7,125,000 shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 3.7% beneficial ownership stake in Fractyl Health, Inc. as of March 31, 2025, held for ordinary course investment purposes.

Multiple Bessemer Venture Partners entities have disclosed beneficial ownership stakes in Fractyl Health, Inc., with Deer VII & Co. Ltd. and Deer VII & Co. L.P. each reporting a 9.9% stake as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.2% beneficial ownership stake in Fractyl Health, Inc. as of December 31, 2024.